Sorrento Therapeutics Inc
A clinical-stage biopharmaceutical company based in San Diego that develops immunotherapies for cancer, autoimmune diseases, and infections, using its own fully human antibody library called G-MAB. Founded in 2006 and later helmed by scientist Henry Ji, it also created the non-opioid ZTlido lidocaine pain patch through its Scilex subsidiary. Its name echoes the seaside Italian town of Sorrento, though the company has never explained the inspiration.
No insider transactions reported in the last 6 months. Look across all recorded history →